Literature DB >> 5775811

Radionuclide decay schemes and nuclear parameters for use in radiation-dose estimation.

L T Dillman.   

Abstract

Mesh:

Substances:

Year:  1969        PMID: 5775811

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


× No keyword cloud information.
  5 in total

1.  Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol.

Authors:  Deepa Rani; Sushma Kaisar; Sushma Awasare; Amit Abhyankar; Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04-01       Impact factor: 9.236

2.  Intrathecal therapy with 198Au-colloid for meningosis prophylaxis.

Authors:  H Döge; R Hliscs
Journal:  Eur J Nucl Med       Date:  1984

Review 3.  Physical and radiobiological bases of the use of 125I in the management of thyrotoxicosis.

Authors:  A R Reddy
Journal:  Radiat Environ Biophys       Date:  1976-10-07       Impact factor: 1.925

4.  Optimum combination of targeted 131I therapy and total-body irradiation for treatment of disseminated tumors of differing radiosensitivity.

Authors:  A E Amin; T E Wheldon; J A O'Donoghue; A Barrett
Journal:  Cell Biophys       Date:  1992 Aug-Dec

5.  Control of the carcinogenic potential of 99mTechnetium by the immunologic hormone lymphotoxin.

Authors:  J H Ransom; C H Evans; A E Jones; R A Zoon; J A DiPaolo
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.